SCHEMBL65346

SCHEMBL65346

C=C(C)C(=O)OCCOc1cccc(OCCOC(=O)C(=C)C)c1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.52
POLB P06746 1/20 0.52
APEX1 P27695 1/20 0.52
HTT P42858 1/20 0.52
MTNR1A P48039 1/20 0.48
MTNR1B P49286 1/20 0.48
THRB P10828 2/20 0.47
L3MBTL1 Q9Y468 3/20 0.46
LMNA P02545 3/20 0.46
MAPK1 P28482 3/20 0.46
MAPT P10636 1/20 0.45
KMT2A Q03164 1/20 0.44
TSHR P16473 3/20 0.43
ALDH1A1 P00352 1/20 0.43
KDM4E B2RXH2 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17033926 0.95 THRB (0.51) TDP1POLBAPEX1HTTMTNR1A
SCHEMBL17037023 0.95 THRB (0.51) TDP1POLBAPEX1HTTMTNR1A
SCHEMBL17033927 0.95 TDP1 (0.56) TDP1POLBAPEX1HTTMTNR1A
SCHEMBL24565136 0.94 MTNR1A (0.57) TDP1POLBAPEX1HTTMTNR1A
SCHEMBL18927230 0.93 TDP1 (0.47) TDP1POLBAPEX1HTTMTNR1A
SCHEMBL17037024 0.92 TDP1 (0.58) TDP1POLBAPEX1HTTMTNR1A
SCHEMBL15385973 0.91 TDP1 (0.52) TDP1POLBAPEX1HTTMTNR1A
SCHEMBL17033933 0.91 TDP1 (0.52) TDP1POLBAPEX1HTTMTNR1A
SCHEMBL24565134 0.91 TDP1 (0.57) TDP1POLBAPEX1HTTL3MBTL1
SCHEMBL17033938 0.90 TDP1 (0.51) TDP1POLBAPEX1HTTMTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5006340-A Methacrylate monomer, polymerization initiator, bactericide MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1991-04-09 US claimed
EP-0115709-B1 READILY CURABLE COMPOSITION MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1989-03-01 EP claimed
EP-0223245-A2 Curable compositions for dental drugs having sustained release property MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1987-05-27 EP claimed
EP-0115709-A2 Readily curable composition MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1984-08-15 EP claimed
US-10392394-B2 Antimicrobial compounds and methods BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2019-08-27 US disclosed
US-10004669-B2 Dental composition and use thereof 3M INNOVATIVE PROPERTIES COMPANY (US) 2018-06-26 US disclosed
US-10004669-B2 Dental composition and use thereof 3M INNOVATIVE PROPERTIES COMPANY (US) 2018-06-26 US disclosed
US-20180155353-A1 Antimicrobial Compounds and Methods BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2018-06-07 US disclosed
US-20180155353-A1 Antimicrobial Compounds and Methods BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2018-06-07 US disclosed
US-9844493-B2 Adhesive bonding composition and use thereof 3M INNOVATIVE PROPERTIES COMPANY (US) 2017-12-19 US disclosed
US-9844493-B2 Adhesive bonding composition and use thereof 3M INNOVATIVE PROPERTIES COMPANY (US) 2017-12-19 US disclosed
US-20170065495-A1 ADHESIVE BONDING COMPOSITION AND USE THEREOF SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2017-03-09 US disclosed
EP-0323521-A1 CURABLE COMPOSITION MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1989-07-12 EP disclosed
US-4830616-A GLUTARALDEHYDE, FERRIC CHLORIDE, EDTA, ACRYLIC ESTER POLYMER, BONDING STRENGTH Okuda, Reiichi (JP) 1989-05-16 US disclosed
US-4826893-A POLYSILSESQUIOXANE-ACRYLIC ESTER COPOLYMER G-C DENTAL INDUSTRIAL CORP. (JP) 1989-05-02 US disclosed
EP-0115709-B1 READILY CURABLE COMPOSITION MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1989-03-01 EP disclosed
US-4758643-A Dental adhesive resin compositions G-C DENTAL INDUSTRIAL CORP. (JP) 1988-07-19 US disclosed
EP-0266220-A2 Curable composition MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1988-05-04 EP disclosed
EP-0223245-A2 Curable compositions for dental drugs having sustained release property MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1987-05-27 EP disclosed
EP-0115709-A2 Readily curable composition MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1984-08-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10392394-B2 Antimicrobial compounds and methods GSDMD, AAAS, ACMSD TDP1 4072/4885POLB 1232/4885APEX1 134/4885
US-20180155353-A1 Antimicrobial Compounds and Methods GSDMD, AAAS, ACMSD TDP1 4072/4885POLB 1232/4885APEX1 134/4885
US-10004669-B2 Dental composition and use thereof ACR, CAD, FHIT TDP1 1119/4885POLB 851/4885APEX1 135/4885
US-20170065495-A1 ADHESIVE BONDING COMPOSITION AND USE THEREOF ICAM1, TAS2R42, CDH1 TDP1 2012/4885POLB 1224/4885APEX1 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.